The Pharmaceutical Task Group (PTG), has urged the Health Department to immediately reconsider the newly gazetted increase of only 1.47%, in the maximum Single Exit Price (SEP) for medicines in 2026. – Business Day (8 Dec 2025)
Business Day reports that, while 2026 medical scheme contribution increases will remain mostly single digit, the Board of Healthcare Funders (BHF) warns that the sector’s stability is artificial, as schemes increasingly rely on reserves to contain costs.
Novo Nordisk’s OASIS 4 phase 3 trial shows that a daily oral Wegovy pill could be a highly effective alternative to the injectable version.
The Health Professions Council of South Africa (HPCSA) has introduced new regulations for end-of-life care and the ethical use of artificial intelligence (AI) in healthcare. The changes aim to safeguard patients while ensuring practitioners adapt to evolving technology and ethical standards.